Biological characteristics of adenomatous nodules, adenomas, and hyperfunctioning nodules as defined by adenylate cyclase activity and TSH receptors.
D000236:Adenoma / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000527:Alprostadil; D002648:Child; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006044:Goiter, Nodular / Q000378:metabolism*; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D006160:Guanosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011458:Prostaglandins E / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011989:Receptors, Thyrotropin; D012969:Sodium Fluoride / Q000494:pharmacology; D013268:Stimulation, Chemical; D013873:Thionucleotides / Q000494:pharmacology; D013959:Thyroid Diseases / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000378:metabolism*
D011458:Prostaglandins E; D011956:Receptors, Cell Surface; D011989:Receptors, Thyrotropin; D013873:Thionucleotides; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D006160:Guanosine Triphosphate; D012969:Sodium Fluoride; D000262:Adenylyl Cyclases; D000527:Alprostadil